WHO Drug Information Vol. 25, No. 2, 2011

More documents

Recommendations

Info

WHO Drug Information Vol. 25, No. 2, 2011ATC/DDD ClassificationATC/DDD Classification (final)The following anatomical therapeutic chemical (ATC) classifications and defined dailydoses (DDDs) were agreed by the WHO International Working Group for Drug StatisticsMethodology in October 2010. They will be included in the January 2012 issueof the ATC index. The inclusion of a substance in the lists does not imply any recommendationof use in medicine or pharmacy. The WHO Collaborating Centre for DrugStatistics Methodology can be contacted at whocc@fhi.no.ATC level INN/Common name ATC codeNew ATC level codes (other than 5th level):Drugs used in hereditary angioedemaB06ACNew ATC 5th level codes:aspoxicillinazilsartan medoxomilbekanamycincabazitaxelcarumonamcefbuperazonecefminoxcinchocaineconestat alfadienogestdimeticonedonepezil and memantinedoxylamine,combinationsecallantideemtricitabine, tenofovirdisoproxil and rilpivirineflomoxeffluindioneiloperidoneipilimumabmeningococcus B,multi-component vaccinemetformin and linagliptinmetformin and saxagliptinmotavizumabpanobinostatpentosan polysulfate sodiumJ01CA19C09CA09J01GB13L01CD04J01DF02J01DC13J01DC12S02DA04B06AC04G03DB08P03AX05N06DA52R06AA59B06AC03J05AR08J01DC14B01AA12N05AX14L01XC11J07AH09A10BD11A10BD10J06BB17L01XX42G04BX15.../...128
WHO Drug Information Vol. 25, No. 2, 2011ATC/DDD ClassificationATC level INN/Common name ATC codepirfenidoneramipril and amlodipinerilpivirinesecukinumabsinecatechinsteduglutidetetrachlorodecaoxidevilazodonevon Willebrand factorL04AX05C09BB07J05AG05L04AC10D06BB12A16AX08D03AX11N06AX24B02BD10ATC code changes:INN/common name Previous ATC New ATCalitretinoin D11AX19 D11AH04C1-inhibitor, plasma derived B02AB03 B06AC01icatibant C01EB19 B06AC02ATC name changesPrevious New ATC codeAgents for atopic dermatitis, excluding Agents for dermatitis,corticosteroids excluding corticosteroids D11AHOther cold combination preparations Other cold preparations R05XNew DDDs:INN/common name DDD Unit Adm.R ATC codeasenapine 20 mg O N05AH05corifollitropin alfa 0.15 mg P G03GA09dienogest 2 mg O G03DB08eltrombopag 50 mg O B02BX05fampridine 20 mg O N07XX07flupirtine 0.4 g O N02BG07indacaterol 0.15 mg Inhal. powder R03AC18indometacin, combinations 0.1 g 1 O,R M01AB51mifamurtide 0.7 mg P L03AX15prucalopride 2 mg O A03AE04roflumilast 0.5 mg O R03DX07velaglucerase alfa 300 U P A16AB101.refers to indometacin129
Page 1 and 2: WHO Drug Information Vol. 25, No. 2
Page 29: WHO Drug Information Vol. 25, No. 2
Page 81 and 82:
WHO Drug Information Vol. 25, No. 2
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
show all

WHO Drug Information Vol. 25, No. 2, 2011

Create successful ePaper yourself

Delete template?

Save as template?